Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.60 B MXN
45.00 B MXN
342.12 M
About NOVONESIS (NOVOZYMES A/S) B
Sector
CEO
Ester Baiget
Headquarters
Lyngby
Website
ISIN
DK0060336014
FIGI
BBG00H0HYRM3
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NSIS/N is 911.11 MXN — it hasn't changed in the past 24 hours. Watch NOVONESIS (NOVOZYMES) B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NOVONESIS (NOVOZYMES) B stocks are traded under the ticker NSIS/N.
We've gathered analysts' opinions on NOVONESIS (NOVOZYMES) B future price: according to them, NSIS/N price has a max estimate of 1,692.02 MXN and a min estimate of 1,029.66 MXN. Watch NSIS/N chart and read a more detailed NOVONESIS (NOVOZYMES) B stock forecast: see what analysts think of NOVONESIS (NOVOZYMES) B and suggest that you do with its stocks.
NSIS/N reached its all-time high on Dec 5, 2024 with the price of 911.11 MXN, and its all-time low was 911.11 MXN and was reached on Mar 11, 2024. View more price dynamics on NSIS/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NSIS/N stock is 0.00% volatile and has beta coefficient of 0.32. Track NOVONESIS (NOVOZYMES) B stock price on the chart and check out the list of the most volatile stocks — is NOVONESIS (NOVOZYMES) B there?
Today NOVONESIS (NOVOZYMES) B has the market capitalization of 531.77 B, it has increased by 0.62% over the last week.
Yes, you can track NOVONESIS (NOVOZYMES) B financials in yearly and quarterly reports right on TradingView.
NOVONESIS (NOVOZYMES) B is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
NSIS/N earnings for the last quarter are 7.89 MXN per share, whereas the estimation was 11.27 MXN resulting in a −30.01% surprise. The estimated earnings for the next quarter are 10.82 MXN per share. See more details about NOVONESIS (NOVOZYMES) B earnings.
NOVONESIS (NOVOZYMES) B revenue for the last quarter amounts to 22.39 B MXN, despite the estimated figure of 22.08 B MXN. In the next quarter, revenue is expected to reach 20.74 B MXN.
NOVONESIS (NOVOZYMES) B dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVONESIS (NOVOZYMES) B on this list?
Like other stocks, NSIS/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS (NOVOZYMES) B stock right from TradingView charts — choose your broker and connect to your account.